GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Other Net Income (Loss)

Aroa Biosurgery (ASX:ARX) Other Net Income (Loss) : A$-0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Other Net Income (Loss)?

Aroa Biosurgery's Other Net Income (Loss) for the six months ended in Mar. 2024 was A$-0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was A$-0.00 Mil.

Aroa Biosurgery's quarterly Other Net Income (Loss) stayed the same from Mar. 2023 (A$0.00 Mil) to Sep. 2023 (A$0.00 Mil) but then declined from Sep. 2023 (A$0.00 Mil) to Mar. 2024 (A$-0.00 Mil).

Aroa Biosurgery's annual Other Net Income (Loss) declined from Mar. 2022 (A$0.00 Mil) to Mar. 2023 (A$-0.00 Mil) and declined from Mar. 2023 (A$-0.00 Mil) to Mar. 2024 (A$-0.00 Mil).


Aroa Biosurgery Other Net Income (Loss) Historical Data

The historical data trend for Aroa Biosurgery's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Other Net Income (Loss) Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Other Net Income (Loss)
- - - - -

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial - - - - -

Aroa Biosurgery Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aroa Biosurgery Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines